Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?

Journal of Surgical Oncology

Volumn 95, Issue 2, 2007, Pages 118-122

  Lim, Suhsien ^a,b   Muhs, Bart E ^a   Marcus, Stuart G ^a   Newman, Elliot ^a   Berman, Russel S ^a   Hiotis, Spiros P ^a  

^a BELLEVUE HOSPITAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Gastrectomy; Gastric cancer; Metastasis; Outcomes; Resection; Stage IV; Surgery

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; ASIAN; CANCER SURGERY; CANCER SURVIVAL; FEMALE; GASTRECTOMY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORBIDITY; MULTIPLE REGRESSION; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; STOMACH CANCER; SURGICAL MORTALITY; SURVIVAL TIME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PALLIATIVE CARE; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 33846898768     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20328     Document Type: Article

References (27)

1. Pyrhonen S, Kuitunen T, Nyandoto P, et al.: Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 1995;71:587-591.
2. Glimelius B, Ekstrom K, Hoffman K, et al.: Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 1997;8:163-168.
3. Monson JR, Donohue JH, McIlrath DC, et al.: Total gastrectomy for advanced cancer. A worthwhile palliative procedure. Cancer 1991;68:1863-1868.
4. Hartgrink HH, Putter H, Kranenbarg EK, et al.: Value of palliative resection in gastric cancer. Br J Surg 2002;89:1438-1443.
5. Haugstvedt T, Viste A, Eide GE, et al.: The survival benefit of resection in patients with advanced stomach cancer: The Norwegian multicenter experience. Norwegian Stomach Cancer Trial. World J Surg 1989;13:617-621; discussion 621-622.
6. Hallissey MT, Allum WH, Roginski C, et al.: Palliative surgery for gastric cancer. Cancer 1988;62:440-444.
7. Ouchi K, Sugawara T, Ono H, et al.: Therapeutic significance of palliative operations for gastric cancer for survival and quality of life. J Surg Oncol 1998;69:41-44.
8. Jeung HC, Rha SY, Jang WI, et al.: Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy. Br J Surg 2002;89:460-466.
9. Esaki Y, Hirayama R, Hirokawa K: A comparison of patterns of metastasis in gastric cancer by histologic type and age. Cancer 1990;65:2086-2090.
10. Cunningham D: Gastric cancer - the recognition of a chemosensitive tumour. Br J Cancer 1988;58:695-699.
11. Kim NK, Park YS, Heo DS, et al.: A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer. Cancer 1993;71:3813-3818.
12. Carmalt HL, Gillett DJ, Hollinshead JW: Carcinoma of the stomach: A review with special reference to total gastrectomy. Aust N Z J Surg 1990;60:759-763.
13. Doglietto GB, Pacelli F, Caprino P, et al.: Palliative surgery for far-advanced gastric cancer: A retrospective study on 305 consecutive patients. Am Surg 1999;65:352-355.
14. Maruyama K, Okabayashi K, Kinoshita T: Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987;11:418-425.
15. Fuchs CS, Mayer RJ: Gastric carcinoma. N Engl J Med 1995;333:32-41.
16. Davis PA, Sano T: The difference in gastric cancer between Japan, USA and Europe: What are the facts? What are the suggestions? Crit Rev Oncol Hematol 2001;40:77-94.
17. Gill S, Shah A, Cook N, et al.: Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a canadian cancer center. J Clin Oncol 2003;21:2070-2076.
18. Schwarz RE, Zagala-Nevarez K: Ethnic survival differences after gastrectomy for gastric cancer are better explained by factors specific for disease location and individual patient comorbidity. Eur J Surg Oncol 2002;28:214-219.
19. Ohno S, Tomisaki S, Oiwa H, et al.: Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach. J Am Coll Surg 1995;180:577-582.
20. Baba H, Maehara Y, Inutsuka S, et al.: Effectiveness of extended lymphadenectomy in noncurative gastrectomy. Am J Surg 1995;169:261-264.
21. Wu CW, Hsieh MC, Lo SS, et al.: Prognostic indicators for survival after curative resection for patients with carcinoma of the stomach. Dig Dis Sci 1997;42:1265-1269.
22. Dhar DK, Kubota H, Tachibana M, et al.: Long-term survival of transmural advanced gastric carcinoma following curative resection: Multivariate analysis of prognostic factors. World J Surg 2000;24:588-593; discussion 593-594.
23. Sanchez-Bueno F, Garcia-Marcilla JA, Perez-Flores D, et al.: Prognostic factors in a series of 297 patients with gastric adenocarcinoma undergoing surgical resection. Br J Surg 1998;85:255-260.
24. Chow LW, Lim BH, Leung SY, et al.: Gastric carcinoma with synchronous liver metastases: Palliative gastrectomy or not? Aust N Z J Surg 1995;65:719-723.
25. Koga S, Kawaguchi H, Kishimoto H, et al.: Therapeutic significance of noncurative gastrectomy for gastric cancer with liver metastasis. Am J Surg 1980;140:356-359.
26. Al-Batran SE, Atmaca A, Hegewisch-Becker S, et al.: Phase II trial of biweekly infusional fluorouracil, folinic acid, and oxaliplatin in patients with advanced gastric cancer. J Clin Oncol 2004;22:658-663.
27. Green D, Ponce de Leon S, Leon-Rodriguez E, et al.: Adenocarcinoma of the stomach: Univariate and multivariate analysis of factors associated with survival. Am J Clin Oncol 2002;25:84-89.